
Home » Pipeline
Pipeline
Company | Drug/Device | Medical Condition | Status |
---|---|---|---|
GT Biopharma Inc. | GTP-004 | myasthenia gravis | Phase I trials initiated |
LivaNova PLC | Perceval sutureless aortic heart valve | diseased native or malfunctioning prosthetic aortic valve | Phase I trials initiated enrolling 160 subjects in China |
Five Prime Therapeutics, Inc. | FPA150 | B7-H4 expression observed in multiple solid tumors, including breast, bladder and gynecologic cancers | Phase I trials initiated |
vTv Therapeutics Inc. | TTP399 | type 1 diabetes | Phase Ib trials initiated |
Allecra Therapeutics | AAI101 | complicated urinary tract infections (cUTIs) | Phase II trials initiated |
Flex Pharma Inc. | FLX-787 | multiple sclerosis | Phase II trials initiated enrolling 57 subjects |
Eiger Biopharmaceuticals, Inc. | exendin 9-39 | post-bariatric hypoglycemia (PBH) | Phase II trials initiated enrolling 36 subjects |
ProMetic Life Sciences Inc. | PBI-4050 | Alström syndrome | Phase II trials initiated enrolling 12 subjects |
MiMedx Group, Inc. | AminoFix Injectable | Plantar Fasciitis | Phase IIb trials initiated enrolling 145 subjects |
MiMedx Group, Inc. | AminoFix Injectable | Osteoarthritis (OA) of the knee | Phase IIb trials initiated enrolling 318 subjects |
BrainStorm Cell Therapeutics Inc. | NurOwn | amyotrophic lateral sclerosis (ALS) | Phase III trials initiated enrolling subjects from Canada |
Urovant Sciences | vibegron | overactive bladder | Phase III trials initiated enrolling 1,400 subjects |
Upcoming Events
-
24May
-
25May
-
28Jun
-
16Oct